When investors look across the financial sector, they often weigh established banking operations against faster-evolving market infrastructure businesses. That contrast comes into focus when examining MS and NDAQ. Morgan Stanley stands as a deposit-based institution that has broadened its wealth and asset-management footprint, while Nasdaq functions as a technology-oriented exchange and data provider. This side-by-side view matters most to those assessing relative performance, valuation gaps, and exposure to capital-markets swings versus steadier, subscription-style revenue.
Morgan Stanley runs three main businesses—Institutional Securities, Wealth Management, and Investment Management—and oversees about $8.4 trillion in client assets. Its latest quarterly report showed revenue climbing roughly 12 percent year over year to around $20.3 billion, with earnings per share reaching $3.03. Return on tangible common equity stayed above 20 percent for the fifth straight quarter.
Even so, shares slipped modestly after the release. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Investors appeared to focus on a softer asset-management segment and the question of whether trading and IPO activity would hold up. Wealth Management continued to stand out, delivering record net new assets of about $232 billion and a pre-tax margin close to 30 percent. Over the past month the stock has retreated roughly 10 to 12 percent and remains behind the broader market year to date, reflecting caution around fee pressure and cyclical capital-markets exposure.
Nasdaq operates through Capital Access Platforms, Financial Technology, and Market Services. It has placed growing emphasis on recurring revenue from data, indexes, and software, with both annualized recurring revenue and SaaS revenue expanding at double-digit rates. In the most recent quarter, net revenue rose about 15 percent to $1.5 billion, and non-GAAP earnings per share increased roughly 25 percent from a year earlier.
Market conditions have supported NDAQ, which benefited from an active IPO calendar that included the listing of SpaceX—the largest IPO in exchange history—and a 74 percent win rate on new operating-company listings. Index exchange-traded product assets under management topped $1 trillion for the first time. The shares trade above both the 50-day and 200-day moving averages, pointing to positive momentum, although the valuation sits well above Morgan Stanley’s, consistent with expectations for durable growth.
The two firms sit at opposite ends of the financial-services spectrum. MS relies more on balance-sheet activities tied to interest rates, credit, and trading volumes, while NDAQ draws a larger portion of revenue from recurring subscriptions, data, and indexes. That difference influences both risk and pricing: Morgan Stanley offers a higher dividend yield and a lower earnings multiple, whereas Nasdaq trades at a premium for more predictable, software-like expansion.
Growth drivers also diverge. Morgan Stanley benefits from wealth-management inflows, IPO-related activity, and trading volumes. Nasdaq gains from financial-technology adoption, anti-financial-crime tools, and index-product development. Recent price action reflects the split as well—Nasdaq has held above key moving averages, while Morgan Stanley consolidated after its earnings release. Sector exposures differ too, with MS more linked to banking and credit conditions and NDAQ more tied to market structure and technology spending. Each faces its own set of risks, ranging from credit and regulatory issues for the bank to valuation sensitivity and transaction-volume dependence for the exchange operator.
Looking at trend consistency, momentum, and recurring-revenue stability, the data point toward a modest edge for NDAQ in the present setting. Nasdaq’s price action above moving averages, its broad double-digit growth, and its move toward steadier revenue streams suggest a more consistent profile. Morgan Stanley, by contrast, provides stronger value and capital returns, yet its recent pullback and greater sensitivity to capital-markets cycles introduce more near-term variability. This remains a probabilistic view rather than a firm call for any particular investor.
I’ve found Tickeron’s AI Trading Bots helpful when comparing names like these. The platform offers hundreds of bots that trade thousands of tickers across different strategies and timeframes. The Trending AI Robots section highlights those best aligned with current conditions, giving a data-driven way to review positioning without replacing core fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 26 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for MS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. MS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.630) is normal, around the industry mean (3.602). P/E Ratio (14.278) is within average values for comparable stocks, (9.027). Projected Growth (PEG Ratio) (1.702) is also within normal values, averaging (0.809). Dividend Yield (0.026) settles around the average of (7.277) among similar stocks. P/S Ratio (4.380) is also within normal values, averaging (16.763).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers